| page | |
| EDITORIALS |
| 1110 | Bringing COPD control into the consultation
|
| 1112 | Diagnosing idiopathic pulmonary fibrosis: Has the time for surgical lung biopsy passed?
Laura M Glenn BMed, MD; Tamera J Corte BSc (Med), MBBS (Hons), FRACP, PhD
10.1111/resp.13909 |
| 1114 | The 4-min mile and supplemental oxygen in IPF
|
| 1116 | Endobronchial coils for emphysema: Do they work and why?
|
| 1119 | Loop gain in paediatric sleep-disordered breathing: A different story from adults
|
| COMMENTARIES |
| 1121 | Exposure to bushfire and biomass smoke and the risk of bacterial and viral lung infection
|
| 1123 | Predictors of response to anti-IL-5 biologics
|
| 1126 | 3D printed airway simulators: Adding a dimension to bronchoscopy training
|
| 1129 | Concise guidance for COPD
Eli Dabscheck MBBS (Hons), M Clin Epi, FRACP; Christine F McDonald AM, MBBS (Hons), PhD, FRACP, FCCP, FThorSoc; Ian A Yang MBBS (Hons), PhD, FRACP, FAPSR, FThorSoc, Grad Dip Clin Epid
10.1111/resp.13934 |
| 1133 | Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19
|
| ORIGINAL ARTICLES |
| COPD |
| 1136 |
Predictive value of control of COPD for risk of exacerbations: An international, prospective study
Marc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, Richard W Costello, Victoria Carter, Jessica H Y Tan, Therese S Lapperre, Bernardino Alcazar, Caroline Gouder, Cristina Esquinas, Juan Luis García-Rivero, Anu Kemppinen, Augustine Tee, Miguel Roman-Rodríguez, Juan José Soler-Cataluña, David B Price on behalf of the Respiratory Effectiveness Group (REG)
10.1111/resp.13811
The concept of control has been well defined in asthma. We have validated the proposal of control status in COPD consisting of easy-to-obtain clinical variables. Patients controlled had a reduced risk of exacerbations compared to uncontrolled patients. |
| Interstitial Lung Disease |
| 1144 |
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study
Giacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, Francesco Varone, Bruno Iovene, Stefania Cerri, Pierluigi Donatelli, Ada Vancheri, Mauro Pavone, Fabrizio Luppi, Carlo Vancheri, Luca Richeldi
10.1111/resp.13805
Disease behaviour is consistent across diagnostic categories of IPF in a real-life clinical setting of patients receiving antifibrotic therapies. If SLB is contraindicated, expert ILD multidisciplinary teams may consider a prompt initiation of treatment when diagnostic confidence for IPF is sufficiently high. |
| 1152 | Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation
Shinichi Arizono, Taiki Furukawa, Hiroyuki Taniguchi, Koji Sakamoto, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Yasuhiro Kondoh
10.1111/resp.13829
In mild–moderate IPF with exercise-induced hypoxaemia even without resting hypoxaemia, supplemental oxygen during exercise improved the endurance time, desaturation and subjective symptoms. |
| Interventional Pulmonology |
| 1160 | Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction
Jorine E Hartman, Pallav L Shah, Frank Sciurba, Felix J F Herth, Dirk-Jan Slebos on behalf of the RENEW Study Group
10.1111/resp.13816
Residual lobar volume reduction in treated lobes measured by QCT was found to be the driving mechanism of action of endobronchial coils leading to positive clinical outcomes. However, the improvement in exercise capacity and quality of life seems to be affected by the presence of cardiac disease. |
| Pleural Disease |
| 1167 | Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer
Ka-Yan Chiang, James Chung-Man Ho, Peony Chong, Terence Chi-Chun Tam, David Chi-Leung Lam, Mary Sau-Man Ip, Yun-Chor Gary Lee, Macy Mei-Sze Lui
10.1111/resp.13812
The availability of efficacious anti-cancer treatments, including oral targeted therapy, do not obviate the need of definitive measures for MPE in newly diagnosed lung cancer. Both early MPE control measures and cancer treatments are warranted to minimize the need of pleural re-interventions in the course of malignancy. |
| Sleep and Ventilation |
| 1174 | Role of ventilatory control instability in children with sleep-disordered breathing
Leon S Siriwardhana, Aidan Weichard, Gillian M Nixon, Margot J Davey, Lisa M Walter, Bradley A Edwards, Rosemary S C Horne
10.1111/resp.13809
The role of physiological traits such as ventilatory control instability in children with SDB is currently unclear. Our study indicates that altered ventilatory control sensitivity may contribute to SDB in a subgroup of children, depending on their degree of upper airway anatomical compromise. |
| POSITION STATEMENTS |
| 1183 | Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia
Ryan Hoy, Jonathan Burdon, Ling Chen, Susan Miles, Jennifer L Perret, Shivonne Prasad, Naghmeh Radhakrishna, Janet Rimmer, Malcolm R Sim, Deborah Yates, Graeme Zosky
10.1111/resp.13951 |
| 1193 | Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
Jennifer L Perret, Susan Miles, Fraser Brims, Katrina Newbigin, Maggie Davidson, Hubertus Jersmann, Adrienne Edwards, Graeme Zosky, Anthony Frankel, Anthony R Johnson, Ryan Hoy, David W Reid, A William Musk, Michael J Abramson, Bob Edwards, Robert Cohen, Deborah H Yates
10.1111/resp.13952 |
| FORUM AND DEBATE |
| Scientific Letter |
| 1203 | Role of endobronchial ultrasound strain elastography in the identification of fibrotic lymph nodes in sarcoidosis: A pilot study
Rocco Trisolini, Roel L J Verhoeven, Alessandra Cancellieri, Annalisa De Silvestri, Filippo Natali, Erik H F M Van der Heijden
10.1111/resp.13900 |
| Correspondences |
| 1207 | Early pleural effusion control in patients with lung cancer
Shinichiro Okauchi MD; Katsunori Kagohashi MD, PhD; Toshihiro Shiozawa MD, PhD Kunihiko Miyazaki MD, PhD; Hiroaki Satoh MD, PhD
10.1111/resp.13902 |
| 1208 | Reply
|
| 1209 | Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern
|
| 1210 | Reply
Stefano Savinelli MD; Cormac McCarthy MD, PhD; Patrick W Mallon MD, PhD; All Ireland Infectious Diseases (AIID) Cohort Collaborators
10.1111/resp.13940 |
| LETTER FROM ASIA-PACIFIC AND BEYOND |
| 1212 | Letter from New Zealand
|
| 1214 | Letter from Iran: Experiences with COVID-19
|
| CORRIGENDUM |
| 1216 | Corrigendum
|
